Advertisement

Topics

DepoMed Company Profile

20:22 EST 12th December 2018 | BioPortfolio

DepoMed, Inc. is a drug delivery company developing new and proprietary oral delivery technologies to improve pharmaceutical products. The company has developed two types of oral drug delivery systems: the Gastric Retention (GR) System and the Reduced Irritation (RI) System.

DepoMed’s strategy is to establish collaborations with pharmaceutical, biotechnology, and generic drug companies to develop and commercialize products utilizing the DepoMed Systems. DepoMed technology can provide pharmaceutical companies with a means of developing new and/or improved products and extending existing patent franchises. New formulations of off-patent drugs developed using DepoMed’s technology may be differentiated from existing generic products by virtue of significant improvements in drug delivery. Concurrently, the company is also developing its own line of proprietary products incorporating off-patent and over-the-counter drugs.

Location

1360 O'Brian Drive
Menlo Park
CA
94025
United States of America

Contact

Phone: 650 462 5900
Fax: (650) 462-9993
Email: TradeRelations@depomedinc.com


News Articles [10 Associated News Articles listed on BioPortfolio]

PDL BioPharma Acquires Depomed’s Remaining 50% Interest in Royalties and Milestones on Type 2 Diabetes Products

INCLINE VILLAGE, Nev., Aug. 2, 2018 /PRNewswire/ — PDL BioPharma, Inc. (“PDL”) (NASDAQ: PDLI) announces an amendment to the Royalty Purchase and Sale Agreement (the “Royalt...

PDL BioPharma, Depomed Amend Royalty Agreement

To acquire all of Depomed's remaining rights on sales of type 2 diabetes products

Depomed, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

Depomed, Inc. Strategy, SWOT and Corporate Finance ReportSummaryDepomed, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report cover...

Depomed, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 31052018] Prices from USD $350

Depomed, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Depomed, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report include...

Depomed's (DEPO) CEO Arthur Higgins on Q2 2018 Results - Earnings Call Transcript

XFRA DPO: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL DEPOMED INC....

Depomed Inc DEPO Financial and Strategic SWOT Analysis Review [Report Updated: 20062018] Prices from USD $125

Depomed Inc DEPO Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData t...

PDL BioPharma (PDLI) - Q318 results

Edison Investment Research - Pharmaceutical & healthcare - PDL BioPharma: PDL reported Q318 revenues of $67.9m, up 8.2% compared to Q317 and up 45.8% sequentially, with that growth mainly due to an in...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Gralise [Depomed, Inc.]

These highlights do not include all the information needed to use GRALISE safely and effectively. See full prescribing information for GRALISE. GRALISE™ (gabapentin) tablets Initial U.S. Approval: 1...

Proquin [Depomed, Inc.]

Proquin XR (ciprofloxacin hydrochloride) Extended-Release Tablets, 500 mg

PubMed Articles [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women

Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of Gabapentin that is being studied for the treatment of Hot Flashes/Hot Flushes in postmenopausal...

Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women.

Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Depomed's Gabapentin Extended Release is an investigational, extended release formulation of gabapentin that is being studied for the treatment of hot flashes in postmenopausal women.

Companies [5 Associated Companies listed on BioPortfolio]

DepoMed

DepoMed, Inc. is a drug delivery company developing new and proprietary oral delivery technologies to improve pharmaceutical products. The company has developed two types of oral drug delivery systems...

Depomed, Inc.

Depomed, Inc. is a specialty pharmaceutical company with one product candidate through Phase 3 clinical development, another in Phase 3 clinical development, two approved products...

Santarus, Inc. and Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by phy...

Santarus, Inc. & Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by phy...

Depomed, Inc. & Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood’s GC-C agonis...

More Information about "DepoMed" on BioPortfolio

We have published hundreds of DepoMed news stories on BioPortfolio along with dozens of DepoMed Clinical Trials and PubMed Articles about DepoMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DepoMed Companies in our database. You can also find out about relevant DepoMed Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record